Male Shiva Ram, Shamanna Bindiganavale R, Bhardwaj Rishi, Bhagvati Chakravarthy, Theagarayan Baskar
School of Medical Sciences University of Hyderabad Gachibowli India.
School of Computer and Information Sciences University of Hyderabad Gachibowli India.
Health Sci Rep. 2022 Sep 22;5(5):e842. doi: 10.1002/hsr2.842. eCollection 2022 Sep.
There is insufficient evidence to support that using electronic or optical color vision devices improve color perception with current advanced technology. The purpose of this study is to compare and analyze the different color vision devices available for patients with color vision deficiency (CVD) and evaluate whether these devices improved their color perception.
This review included randomized, experimental, comparative studies, as well as narrative reviews, prototype and innovation studies, and translational studies, followed by case-control and clinical trials with nonsurgical interventions studies, that is, electronic color vision devices, optical devices, and contact lens-based studies, with standardized inclusion and exclusion criteria.
The primary outcome studied was the performance of color vision devices, both objective and subjective. Secondary outcomes included the ease of use and accessibility of color vision devices and technology. The grading of recommendation, assessment, development, and evaluation framework was used to develop a systematic approach for consideration and clinical practice recommendation for CVD devices for color-deficient populations. We incorporated meta-analysis reports from a total of = 16 studies that met the criteria which consisted of case-control studies, prototype and innovation studies, comparative studies, pre- and post-clinical trial studies, case studies, and narrative reviews. Proportion and standard errors, as well as correlations, were calculated from the meta-analysis for various available color vision devices.
This review concludes that commercially available color vision devices, such as EnChroma Glasses, Chromagen filters, and EnChroma Cx-14 do not provide clinically significant evidence that subjective color perception has improved. As a result, recommending these color vision devices to the CVD population may not prove high beneficial/be counterproductive. However, only a few color shades can be perceived differently. This systematic review and analysis will aid future research and development in color vision devices.
目前尚无充分证据支持使用电子或光学色觉设备借助当前先进技术改善色觉。本研究的目的是比较和分析可供色觉缺陷(CVD)患者使用的不同色觉设备,并评估这些设备是否改善了他们的色觉。
本综述纳入了随机、实验、比较研究,以及叙述性综述、原型与创新研究和转化研究,随后是采用非手术干预的病例对照和临床试验研究,即电子色觉设备、光学设备和基于隐形眼镜的研究,并制定了标准化的纳入和排除标准。
所研究的主要结局是色觉设备的客观和主观性能。次要结局包括色觉设备和技术的易用性和可及性。使用推荐分级、评估、发展与评价框架来制定一种系统方法,以考虑并为色觉缺陷人群的CVD设备提出临床实践建议。我们纳入了总共16项符合标准的研究的荟萃分析报告,这些研究包括病例对照研究、原型与创新研究、比较研究、临床前和临床试验研究、病例研究以及叙述性综述。通过荟萃分析计算了各种可用色觉设备的比例、标准误差以及相关性。
本综述得出结论,市售的色觉设备,如EnChroma眼镜、Chromagen滤光片和EnChroma Cx - 14,没有提供主观色觉已得到改善的临床显著证据。因此,向CVD人群推荐这些色觉设备可能并无太大益处/甚至适得其反。然而,只有少数几种颜色阴影能被不同程度地感知。这种系统综述和分析将有助于色觉设备的未来研发。